Richard J. Cote, MD, FRCPath, FCAP

Top Doctors®

Specializes In
  • Pathology

Appointments

Sees Patients For

Pathology and immunology

Locations

Experience

Board Certifications

  • Pathology

Academic Title(s)

Professor and Chair, Department of Pathology and Immunology

Publications & Research

Search PubMed for publications »

Education

Clinical Fellowship: Surgical Pathology

1990 Memorial Sloan-Kettering Cancer Center

Research Fellowship: Molecular Pathology

1990 New York University School of Medicine, New York, NY

Residency: Pathology

1987 Cornell University Medical College, New York Hospital

Research Fellowship: Human Tumor Pathology

1983 Memorial Sloan-Kettering Cancer Center

Medical Degree

1980 University of Chicago Pritzker School of Medicine, Chicago, IL

Financial Disclosures
  • Circulogix
    • Royalties: $1 - $9,999
    • Equity: Yes
    • Reporting Date: 05/01/2022
  • Illumina
    • Royalties: > $250,000
    • Reporting Date: 05/01/2022

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.